Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending October 1, 2021

Overall drug TRx are +1.1% w/w

Vascepa
TRx 81,199; -1.8% (-1,468) w/w; -11.4% y/y
NRx 37,243; -0.4% (-151) w/w; -13.1% y/y
Ref 43,956; -2.9% (-1,317) w/w; -9.9% y/y

Lovaza (Generic & Brand)
TRx 63,136; -1.6% (-1,054) w/w; -0.8% y/y
NRx 31,085; -0.3% (-81) w/w; -3.3% y/y
Ref 32,051; -2.9% (-973) w/w; +1.7% y/y

Generic Vascepa
TRx 18,591; -2.9% (-552) w/w; As % of total V: 18.6%
NRx 10,568; -1.8% (-189) w/w; As % of total V: 22.1%
Ref 8,023; -4.3% (-363) w/w; As % of total V: 15.4%

Generic Vascepa by Manufacturer
Hikma - TRx 12,131 (-622); Generic share 65.3%; Total V share 12.2%
Reddy - TRx 6,460 (+69); Generic share 34.7%; Total V share 6.5%

TRx Vascepa + Generic Vascepa: 99,790 (-2,020)